RET-IN-21
Product Specifications
UNSPSC Description
RET-IN-21 is an inhibitor of receptor tyrosine kinase (RET), with the IC50 of 4.4 μM, that has antitumor activity[1].
Target Antigen
RET
Type
Reference compound
Related Pathways
Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
cancer
Assay Protocol
https://www.medchemexpress.com/ret-in-21.html
Solubility
DMSO : 125 mg/mL (ultrasonic)
Smiles
O=C(N)C1=CC=C(C2=C3N=C(NCC4=CC=NC=C4)C=CN3N=C2)C=C1
Molecular Weight
344.37
References & Citations
[1]Rebecca Newton, et al. Discovery and Optimization of wt-RET/KDR-Selective Inhibitors of RETV804M Kinase. ACS Med. Chem. Lett. 2020, 11, 4, 497–505
Shipping Conditions
Room Temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-148742/RET-IN-21-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-148742/RET-IN-21-SDS-MedChemExpress.pdf
Clinical Information
No Development Reported
CAS Number
2414373-42-3
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
![Mouse Monoclonal RhoD Antibody (OTI2F7) [DyLight 650]](https://cdn.genprice.uk/genprice/genprice5.png)
GPR113 (ADGRF3) (NM_001145168) Human Tagged ORF Clone Lentiviral Particle
![Rat Monoclonal CCL9 Antibody (RM0185-28B3) [Janelia Fluor 646]](https://cdn.genprice.uk/genprice/genprice3.png)
Rat Monoclonal CCL9 Antibody (RM0185-28B3) [Janelia Fluor 646]